FDA Further Limits Johnson & Johnson Covid Vaccine

FDA Further Limits Johnson & Johnson Covid Vaccine

Johnson & & Johnson was eclipsed long ago by Pfizer and Moderna in the country’s vaccination project; federal authorities have said the mRNA vaccines produced by those companies are both safer and more effective. In a statement, Johnson & & Johnson said the F.D.A.’s action reflected the already-known risk of the side impact, not new data on the rate at which it takes place. The number of deaths associated to the disorder activated by the Johnson & & Johnson’s vaccine does not appear to have increased much, if at all. About 17 million Americans have actually now gotten one dosage of Johnson & & Johnson’s vaccine, and another 1.5 million have actually gotten a booster dose, according to the C.D.C.’s information.

Johnson & & Johnson was eclipsed long back by Pfizer and Moderna in the nation’s vaccination project; federal officials have said the mRNA vaccines produced by those companies are both more secure and more efficient. The number of deaths attributed to the disorder set off by the Johnson & & Johnson’s vaccine does not appear to have risen much, if at all. About 17 million Americans have actually now gotten one dosage of Johnson & & Johnson’s vaccine, and another 1.5 million have actually gotten a booster dosage, according to the C.D.C.’s data.

Leave a Reply

Your email address will not be published. Required fields are marked *


*